StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.43+0.07 (+2.97%)

Close on Nov 18, 2026Market cap $309.52MP/E –Yield –

Nautilus Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$234.00K–
Q2 FY2026Jun 30, 2026$190.00K–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–

More Nautilus Biotechnology figures

See a number that looks wrong?